Primary CD56+ NK Cells - Global and China Top Players Market Share and Ranking 2023
According to the Latest Research Report,, the global market for Primary CD56+ NK Cells should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Primary CD56+ NK Cells market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Primary CD56+ NK Cells market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Compound Screening grew percent to account for percent of the total market sales, and Immune Function Assay grew percent.
Primary CD56+ Natural killer (NK) cells are the major effectors of the innate immune system and are important in host defense, cancer, and autoimmunity. CD56+ Natural Killer Cells are isolated from mononuclear cells by negative selection using immunomagnetic cell separation procedures.
This report studies and analyses global Primary CD56+ NK Cells status and future trends, helps the client to determine the Primary CD56+ NK Cells market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Primary CD56+ NK Cells, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Primary CD56+ NK Cells market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Primary CD56+ NK Cells sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Primary CD56+ NK Cells sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Primary CD56+ NK Cells key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Primary CD56+ NK Cells key producing regions, capacity, production, and year over year growth
(6) Primary CD56+ NK Cells industry chains, upstream, midstream and downstream
Market segment by players, this report covers
PBM
ATCC
STEMCEITM
Thermo Fisher Scientific
AllCells
ABM
3H Biomedical
ProMab Biotechnologies
AcceGen
AMSBIO
Clinisciences
Creative Bioarray
iCell Bioscience
Shenzhen Kingfocus Biomedical
Market segment by Type, covers
Custom Made
Bulk
Market segment by Application, can be divided into
Compound Screening
Immune Function Assay
Drug Discovery
Others
Key Regions Covered in This Report Are:
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
The Report Consists of The Following Points:
Chapter 1: to describe Primary CD56+ NK Cells product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Primary CD56+ NK Cells market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Primary CD56+ NK Cells market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Primary CD56+ NK Cells, percent & CAGR, 2018-2029
Chapter 5: Primary CD56+ NK Cells industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Primary CD56+ NK Cells Definition
1.2 Global Primary CD56+ NK Cells Market Size and Forecast
1.2.1 By Consumption Value, Global Primary CD56+ NK Cells Market Size，2018-2029
1.2.2 By Sales Quantity, Global Primary CD56+ NK Cells Market Size，2018-2029
1.2.3 Global Primary CD56+ NK Cells Average Selling Price (ASP)，2018-2029
1.3 China Primary CD56+ NK Cells Market Size and Forecast
1.3.1 By Consumption Value, China Primary CD56+ NK Cells Market Size，2018-2029
1.3.2 By Sales Quantity, China Primary CD56+ NK Cells Market Size，2018-2029
1.3.3 China Primary CD56+ NK Cells Average Selling Price (ASP)， 2018-2029
1.4 Share of China Primary CD56+ NK Cells Market with Respect to the Global Market
1.4.1 By Consumption Value, China Primary CD56+ NK Cells Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Primary CD56+ NK Cells Market Share in Global, 2018-2029
1.4.3 Primary CD56+ NK Cells Market Size: China VS Global, 2018-2029
1.5 Primary CD56+ NK Cells Market Dynamics
1.5.1 Primary CD56+ NK Cells Market Drivers
1.5.2 Primary CD56+ NK Cells Market Restraints
1.5.3 Primary CD56+ NK Cells Industry Trends
1.5.4 Primary CD56+ NK Cells Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Primary CD56+ NK Cells, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Primary CD56+ NK Cells, Global Market Share by Company, 2018-2023
2.3 Primary CD56+ NK Cells Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Primary CD56+ NK Cells Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Primary CD56+ NK Cells Concentration Ratio
2.6 Global Primary CD56+ NK Cells Mergers & Acquisitions, Expansion Plans
2.7 Global Primary CD56+ NK Cells Manufacturers Product Type
2.8 Head Office and Primary CD56+ NK Cells Production Site of Key Manufacturer
2.9 Primary CD56+ NK Cells Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Primary CD56+ NK Cells, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Primary CD56+ NK Cells, China Market Share by Company, 2018-2023
3.3 China Primary CD56+ NK Cells Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Primary CD56+ NK Cells Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Primary CD56+ NK Cells Capacity by Region
4.3 Global Primary CD56+ NK Cells Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Primary CD56+ NK Cells Production by Region, 2018-2029
4.5 Global Primary CD56+ NK Cells Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Primary CD56+ NK Cells Industry Chain
5.2 Primary CD56+ NK Cells Upstream Analysis
5.2.1 Primary CD56+ NK Cells Core Raw Materials
5.2.2 Main Manufacturers of Primary CD56+ NK Cells Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Primary CD56+ NK Cells Production Mode
5.6 Primary CD56+ NK Cells Procurement Model
5.7 Primary CD56+ NK Cells Industry Sales Model and Sales Channels
5.7.1 Primary CD56+ NK Cells Sales Model
5.7.2 Primary CD56+ NK Cells Typical Distributors
6 Sights by Type
6.1 Primary CD56+ NK Cells Classification
6.1.1 Custom Made
6.1.2 Bulk
6.2 By Type, Global Primary CD56+ NK Cells Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Primary CD56+ NK Cells Consumption Value, 2018-2029
6.4 By Type, Global Primary CD56+ NK Cells Sales Quantity, 2018-2029
6.5 By Type, Global Primary CD56+ NK Cells Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Primary CD56+ NK Cells Segment by Application
7.1.1 Compound Screening
7.1.2 Immune Function Assay
7.1.3 Drug Discovery
7.1.4 Others
7.2 By Application, Global Primary CD56+ NK Cells Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Primary CD56+ NK Cells Consumption Value, 2018-2029
7.4 By Application, Global Primary CD56+ NK Cells Sales Quantity, 2018-2029
7.5 By Application, Global Primary CD56+ NK Cells Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Primary CD56+ NK Cells Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Primary CD56+ NK Cells Consumption Value, 2018-2029
8.3 By Region, Global Primary CD56+ NK Cells Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Primary CD56+ NK Cells & Forecasts, 2018-2029
8.4.2 By Country, North America Primary CD56+ NK Cells Market Size Market Share
8.5 Europe
8.5.1 Europe Primary CD56+ NK Cells Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Primary CD56+ NK Cells Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Primary CD56+ NK Cells Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Primary CD56+ NK Cells Market Size Market Share
8.7 South America
8.7.1 South America Primary CD56+ NK Cells Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Primary CD56+ NK Cells Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Primary CD56+ NK Cells Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Primary CD56+ NK Cells Consumption Value, 2018-2029
9.3 By Country, Global Primary CD56+ NK Cells Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Primary CD56+ NK Cells Market Size, 2018-2029
9.4.2 By Type, U.S. Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Primary CD56+ NK Cells Market Size, 2018-2029
9.5.2 By Type, Europe Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Primary CD56+ NK Cells Market Size, 2018-2029
9.6.2 By Type, China Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Primary CD56+ NK Cells Market Size, 2018-2029
9.7.2 By Type, Japan Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Primary CD56+ NK Cells Market Size, 2018-2029
9.8.2 By Type, South Korea Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Primary CD56+ NK Cells Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Primary CD56+ NK Cells Market Size, 2018-2029
9.10.2 By Type, India Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Primary CD56+ NK Cells Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 PBM
10.1.1 PBM Company Information, Head Office, Market Area, and Industry Position
10.1.2 PBM Primary CD56+ NK Cells Models, Specifications, and Application
10.1.3 PBM Primary CD56+ NK Cells Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 PBM Company Profile and Main Business
10.1.5 PBM Recent Developments
10.2 ATCC
10.2.1 ATCC Company Information, Head Office, Market Area, and Industry Position
10.2.2 ATCC Primary CD56+ NK Cells Models, Specifications, and Application
10.2.3 ATCC Primary CD56+ NK Cells Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 ATCC Company Profile and Main Business
10.2.5 ATCC Recent Developments
10.3 STEMCEITM
10.3.1 STEMCEITM Company Information, Head Office, Market Area, and Industry Position
10.3.2 STEMCEITM Primary CD56+ NK Cells Models, Specifications, and Application
10.3.3 STEMCEITM Primary CD56+ NK Cells Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 STEMCEITM Company Profile and Main Business
10.3.5 STEMCEITM Recent Developments
10.4 Thermo Fisher Scientific
10.4.1 Thermo Fisher Scientific Company Information, Head Office, Market Area, and Industry Position
10.4.2 Thermo Fisher Scientific Primary CD56+ NK Cells Models, Specifications, and Application
10.4.3 Thermo Fisher Scientific Primary CD56+ NK Cells Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Thermo Fisher Scientific Company Profile and Main Business
10.4.5 Thermo Fisher Scientific Recent Developments
10.5 AllCells
10.5.1 AllCells Company Information, Head Office, Market Area, and Industry Position
10.5.2 AllCells Primary CD56+ NK Cells Models, Specifications, and Application
10.5.3 AllCells Primary CD56+ NK Cells Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 AllCells Company Profile and Main Business
10.5.5 AllCells Recent Developments
10.6 ABM
10.6.1 ABM Company Information, Head Office, Market Area, and Industry Position
10.6.2 ABM Primary CD56+ NK Cells Models, Specifications, and Application
10.6.3 ABM Primary CD56+ NK Cells Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 ABM Company Profile and Main Business
10.6.5 ABM Recent Developments
10.7 3H Biomedical
10.7.1 3H Biomedical Company Information, Head Office, Market Area, and Industry Position
10.7.2 3H Biomedical Primary CD56+ NK Cells Models, Specifications, and Application
10.7.3 3H Biomedical Primary CD56+ NK Cells Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 3H Biomedical Company Profile and Main Business
10.7.5 3H Biomedical Recent Developments
10.8 ProMab Biotechnologies
10.8.1 ProMab Biotechnologies Company Information, Head Office, Market Area, and Industry Position
10.8.2 ProMab Biotechnologies Primary CD56+ NK Cells Models, Specifications, and Application
10.8.3 ProMab Biotechnologies Primary CD56+ NK Cells Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 ProMab Biotechnologies Company Profile and Main Business
10.8.5 ProMab Biotechnologies Recent Developments
10.9 AcceGen
10.9.1 AcceGen Company Information, Head Office, Market Area, and Industry Position
10.9.2 AcceGen Primary CD56+ NK Cells Models, Specifications, and Application
10.9.3 AcceGen Primary CD56+ NK Cells Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 AcceGen Company Profile and Main Business
10.9.5 AcceGen Recent Developments
10.10 AMSBIO
10.10.1 AMSBIO Company Information, Head Office, Market Area, and Industry Position
10.10.2 AMSBIO Primary CD56+ NK Cells Models, Specifications, and Application
10.10.3 AMSBIO Primary CD56+ NK Cells Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 AMSBIO Company Profile and Main Business
10.10.5 AMSBIO Recent Developments
10.11 Clinisciences
10.11.1 Clinisciences Company Information, Head Office, Market Area, and Industry Position
10.11.2 Clinisciences Primary CD56+ NK Cells Models, Specifications, and Application
10.11.3 Clinisciences Primary CD56+ NK Cells Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Clinisciences Company Profile and Main Business
10.11.5 Clinisciences Recent Developments
10.12 Creative Bioarray
10.12.1 Creative Bioarray Company Information, Head Office, Market Area, and Industry Position
10.12.2 Creative Bioarray Primary CD56+ NK Cells Models, Specifications, and Application
10.12.3 Creative Bioarray Primary CD56+ NK Cells Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Creative Bioarray Company Profile and Main Business
10.12.5 Creative Bioarray Recent Developments
10.13 iCell Bioscience
10.13.1 iCell Bioscience Company Information, Head Office, Market Area, and Industry Position
10.13.2 iCell Bioscience Primary CD56+ NK Cells Models, Specifications, and Application
10.13.3 iCell Bioscience Primary CD56+ NK Cells Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 iCell Bioscience Company Profile and Main Business
10.13.5 iCell Bioscience Recent Developments
10.14 Shenzhen Kingfocus Biomedical
10.14.1 Shenzhen Kingfocus Biomedical Company Information, Head Office, Market Area, and Industry Position
10.14.2 Shenzhen Kingfocus Biomedical Primary CD56+ NK Cells Models, Specifications, and Application
10.14.3 Shenzhen Kingfocus Biomedical Primary CD56+ NK Cells Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Shenzhen Kingfocus Biomedical Company Profile and Main Business
10.14.5 Shenzhen Kingfocus Biomedical Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Primary CD56+ NK Cells Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Primary CD56+ NK Cells Market Restraints
Table 3. Primary CD56+ NK Cells Market Trends
Table 4. Primary CD56+ NK Cells Industry Policy
Table 5. Global Primary CD56+ NK Cells Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Primary CD56+ NK Cells Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Primary CD56+ NK Cells Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Primary CD56+ NK Cells Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Primary CD56+ NK Cells Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Primary CD56+ NK Cells Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Primary CD56+ NK Cells Mergers & Acquisitions, Expansion Plans
Table 12. Global Primary CD56+ NK Cells Manufacturers Product Type
Table 13. Head Office and Primary CD56+ NK Cells Production Site of Key Manufacturer
Table 14. Primary CD56+ NK Cells Capacity of Major Manufacturers and Future Plan
Table 15. China Primary CD56+ NK Cells Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Primary CD56+ NK Cells Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Primary CD56+ NK Cells Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Primary CD56+ NK Cells Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Primary CD56+ NK Cells Production by Region, 2018-2023, (K Units)
Table 20. Global Primary CD56+ NK Cells Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Primary CD56+ NK Cells Upstream (Raw Materials)
Table 22. Global Primary CD56+ NK Cells Typical Customers
Table 23. Primary CD56+ NK Cells Typical Distributors
Table 24. By Type, Global Primary CD56+ NK Cells Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Primary CD56+ NK Cells Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Primary CD56+ NK Cells Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Primary CD56+ NK Cells Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Primary CD56+ NK Cells Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Primary CD56+ NK Cells Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Primary CD56+ NK Cells Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Primary CD56+ NK Cells Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Primary CD56+ NK Cells Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Primary CD56+ NK Cells Sales Quantity Market Share, 2018-2029
Table 34. PBM Company Information, Head Office, Market Area, and Industry Position
Table 35. PBM Primary CD56+ NK Cells Models, Specifications, and Application
Table 36. PBM Primary CD56+ NK Cells Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. PBM Company Profile and Main Business
Table 38. PBM Recent Developments
Table 39. ATCC Company Information, Head Office, Market Area, and Industry Position
Table 40. ATCC Primary CD56+ NK Cells Models, Specifications, and Application
Table 41. ATCC Primary CD56+ NK Cells Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. ATCC Company Profile and Main Business
Table 43. ATCC Recent Developments
Table 44. STEMCEITM Company Information, Head Office, Market Area, and Industry Position
Table 45. STEMCEITM Primary CD56+ NK Cells Models, Specifications, and Application
Table 46. STEMCEITM Primary CD56+ NK Cells Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. STEMCEITM Company Profile and Main Business
Table 48. STEMCEITM Recent Developments
Table 49. Thermo Fisher Scientific Company Information, Head Office, Market Area, and Industry Position
Table 50. Thermo Fisher Scientific Primary CD56+ NK Cells Models, Specifications, and Application
Table 51. Thermo Fisher Scientific Primary CD56+ NK Cells Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Thermo Fisher Scientific Company Profile and Main Business
Table 53. Thermo Fisher Scientific Recent Developments
Table 54. AllCells Company Information, Head Office, Market Area, and Industry Position
Table 55. AllCells Primary CD56+ NK Cells Models, Specifications, and Application
Table 56. AllCells Primary CD56+ NK Cells Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. AllCells Company Profile and Main Business
Table 58. AllCells Recent Developments
Table 59. ABM Company Information, Head Office, Market Area, and Industry Position
Table 60. ABM Primary CD56+ NK Cells Models, Specifications, and Application
Table 61. ABM Primary CD56+ NK Cells Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. ABM Company Profile and Main Business
Table 63. ABM Recent Developments
Table 64. 3H Biomedical Company Information, Head Office, Market Area, and Industry Position
Table 65. 3H Biomedical Primary CD56+ NK Cells Models, Specifications, and Application
Table 66. 3H Biomedical Primary CD56+ NK Cells Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. 3H Biomedical Company Profile and Main Business
Table 68. 3H Biomedical Recent Developments
Table 69. ProMab Biotechnologies Company Information, Head Office, Market Area, and Industry Position
Table 70. ProMab Biotechnologies Primary CD56+ NK Cells Models, Specifications, and Application
Table 71. ProMab Biotechnologies Primary CD56+ NK Cells Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. ProMab Biotechnologies Company Profile and Main Business
Table 73. ProMab Biotechnologies Recent Developments
Table 74. AcceGen Company Information, Head Office, Market Area, and Industry Position
Table 75. AcceGen Primary CD56+ NK Cells Models, Specifications, and Application
Table 76. AcceGen Primary CD56+ NK Cells Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. AcceGen Company Profile and Main Business
Table 78. AcceGen Recent Developments
Table 79. AMSBIO Company Information, Head Office, Market Area, and Industry Position
Table 80. AMSBIO Primary CD56+ NK Cells Models, Specifications, and Application
Table 81. AMSBIO Primary CD56+ NK Cells Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. AMSBIO Company Profile and Main Business
Table 83. AMSBIO Recent Developments
Table 84. Clinisciences Company Information, Head Office, Market Area, and Industry Position
Table 85. Clinisciences Primary CD56+ NK Cells Models, Specifications, and Application
Table 86. Clinisciences Primary CD56+ NK Cells Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Clinisciences Company Profile and Main Business
Table 88. Clinisciences Recent Developments
Table 89. Creative Bioarray Company Information, Head Office, Market Area, and Industry Position
Table 90. Creative Bioarray Primary CD56+ NK Cells Models, Specifications, and Application
Table 91. Creative Bioarray Primary CD56+ NK Cells Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Creative Bioarray Company Profile and Main Business
Table 93. Creative Bioarray Recent Developments
Table 94. iCell Bioscience Company Information, Head Office, Market Area, and Industry Position
Table 95. iCell Bioscience Primary CD56+ NK Cells Models, Specifications, and Application
Table 96. iCell Bioscience Primary CD56+ NK Cells Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. iCell Bioscience Company Profile and Main Business
Table 98. iCell Bioscience Recent Developments
Table 99. Shenzhen Kingfocus Biomedical Company Information, Head Office, Market Area, and Industry Position
Table 100. Shenzhen Kingfocus Biomedical Primary CD56+ NK Cells Models, Specifications, and Application
Table 101. Shenzhen Kingfocus Biomedical Primary CD56+ NK Cells Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Shenzhen Kingfocus Biomedical Company Profile and Main Business
Table 103. Shenzhen Kingfocus Biomedical Recent Developments
List of Figures
Figure 1. Primary CD56+ NK Cells Picture
Figure 2. Global Primary CD56+ NK Cells Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Primary CD56+ NK Cells Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Primary CD56+ NK Cells Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Primary CD56+ NK Cells Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Primary CD56+ NK Cells Sales Quantity (K Units) & (2018-2029)
Figure 7. China Primary CD56+ NK Cells Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Primary CD56+ NK Cells Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Primary CD56+ NK Cells Market Share of Global, 2018-2029
Figure 10. Global Primary CD56+ NK Cells Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Primary CD56+ NK Cells Key Participants, Market Share, 2022
Figure 12. Global Primary CD56+ NK Cells Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Primary CD56+ NK Cells Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Primary CD56+ NK Cells Production Market Share & Forecast by Region, 2018-2029
Figure 15. Primary CD56+ NK Cells Industry Chain
Figure 16. Primary CD56+ NK Cells Procurement Model
Figure 17. Primary CD56+ NK Cells Sales Model
Figure 18. Primary CD56+ NK Cells Sales Channels, Direct Sales, and Distribution
Figure 19. Custom Made
Figure 20. Bulk
Figure 21. By Type, Global Primary CD56+ NK Cells Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Primary CD56+ NK Cells Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Primary CD56+ NK Cells Sales Quantity, 2018-2029, (K Units)
Figure 24. By Type, Global Primary CD56+ NK Cells Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Primary CD56+ NK Cells Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 26. Compound Screening
Figure 27. Immune Function Assay
Figure 28. Drug Discovery
Figure 29. Others
Figure 30. By Application, Global Primary CD56+ NK Cells Consumption Value, 2018-2029, US$ Million
Figure 31. By Application, Global Primary CD56+ NK Cells Consumption Value Market Share, 2018-2029
Figure 32. By Application, Global Primary CD56+ NK Cells Sales Quantity, 2018-2029, (K Units)
Figure 33. By Application, Global Primary CD56+ NK Cells Sales Quantity Market Share, 2018-2029
Figure 34. By Application, Global Primary CD56+ NK Cells Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 35. By Region, Global Primary CD56+ NK Cells Consumption Value Market Share, 2018-2029
Figure 36. By Region, Global Primary CD56+ NK Cells Sales Quantity Market Share, 2018-2029
Figure 37. North America Primary CD56+ NK Cells Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 38. By Country, North America Primary CD56+ NK Cells Consumption Value Market Share, 2022
Figure 39. Europe Primary CD56+ NK Cells Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, Europe Primary CD56+ NK Cells Consumption Value Market Share, 2022
Figure 41. Asia Pacific Primary CD56+ NK Cells Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country/Region, Asia Pacific Primary CD56+ NK Cells Consumption Value Market Share, 2022
Figure 43. South America Primary CD56+ NK Cells Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, South America Primary CD56+ NK Cells Consumption Value Market Share, 2022
Figure 45. Middle East & Africa Primary CD56+ NK Cells Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 46. U.S. Primary CD56+ NK Cells Sales Quantity, 2018-2029, (K Units)
Figure 47. By Type, U.S. Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
Figure 48. By Application, U.S. Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
Figure 49. Europe Primary CD56+ NK Cells Sales Quantity, 2018-2029, (K Units)
Figure 50. By Type, Europe Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
Figure 51. By Application, Europe Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
Figure 52. China Primary CD56+ NK Cells Sales Quantity, 2018-2029, (K Units)
Figure 53. By Type, China Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
Figure 54. By Application, China Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
Figure 55. Japan Primary CD56+ NK Cells Sales Quantity, 2018-2029, (K Units)
Figure 56. By Type, Japan Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
Figure 57. By Application, Japan Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
Figure 58. South Korea Primary CD56+ NK Cells Sales Quantity, 2018-2029, (K Units)
Figure 59. By Type, South Korea Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
Figure 60. By Application, South Korea Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
Figure 61. Southeast Asia Primary CD56+ NK Cells Sales Quantity, 2018-2029, (K Units)
Figure 62. By Type, Southeast Asia Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
Figure 63. By Application, Southeast Asia Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
Figure 64. India Primary CD56+ NK Cells Sales Quantity, 2018-2029, (K Units)
Figure 65. By Type, India Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
Figure 66. By Application, India Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
Figure 67. Middle East & Africa Primary CD56+ NK Cells Sales Quantity, 2018-2029, (K Units)
Figure 68. By Type, Middle East & Africa Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
Figure 69. By Application, Middle East & Africa Primary CD56+ NK Cells Sales Quantity Market Share, 2022 VS 2029
Figure 70. Research Methodology
Figure 71. Breakdown of Primary Interviews
Figure 72. Bottom-up and Top-down Approaches
Figure 73. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|